NCIRS 网络研讨会 - 与 COVID-19 一起生活：像往常一样恢复免疫接种业务
NCIRS 将于 3 月 3 日星期四举办网络研讨会，届时将有一组专家发言，其中包括 MVEC 的 A/Nigel Crawford 教授。网络研讨会的主题是 与 COVID-19 一起生活：照常进行免疫接种 并将涵盖：
- 澳大利亚 COVID‑19 疫苗建议的更新
- 区域和全球范围内的 COVID-19 和常规免疫计划——需要什么
- 新的 COVID-19 疫苗——我们是否需要改变我们的策略以应对新的变种？
有关注册的更多信息和详细信息，请访问以下链接：
NCIRS 网络研讨会 - 与 COVID-19 一起生活：像往常一样恢复免疫接种业务
Clinical Vaccinology Update session recordings now available
我们最近的临床疫苗学更新 (CVU) 的会议记录现在可以通过我们的 MVEC Education Portal Homepage.
To access the recordings, attendees can sign in to our Education Portal using their existing account details or simply create an account if are a new user.
如果您没有参加活动但想访问录音，您可以通过我们的购买访问权限 Events Page.
如果您对我们的 CVU 活动有任何疑问，请联系 [email protected].
Last chance to register for day 2 of our Clinical Vaccinology Update (CVU)
There's still time to register for the final day of our Clinical Vaccinology Update (CVU) and hear from leading experts addressing the most important issues in immunisation.
Tomorrow we're excited to be hosting a panel session with Professor Julie Leask, Dr Preeya Alexander and A/Prof Nigel Crawford on mandatory vaccination and no fault compensation!
To register for the event, please click on the link below:
MVEC Clinical Vaccinology Update (CVU) 2021
Healthed Going Viral Podcast featuring A/Prof Nigel Crawford
MVEC’s Associate Professor Nigel Crawford delivered the COVID-19 Update as part of the recent Healthed Australia online lecture series.
In this lecture, A/Prof Nigel Crawford discussed the following:
- COVID booster dose
- Myocarditis following mRNA vaccine
- Vaccinating 5-11-year-olds with Pfizer
- Best vaccine delivery method
- Opening the borders – don’t forget there are many vaccine-preventable diseases (VPDs)
To listen to the lecture in full, click on the link below:
Healthed lecture series 11 November: COVID-19 Update
There's still time to register for the Clinical Vaccinology Update (CVU) 2021!
There's still time to register for the Clinical Vaccinology Update (CVU) 2021 taking place virtually on Thursday 18th and Friday 19th November.
This 2-day virtual program will allow participants to choose from keynote sessions delivered on our virtual main stage in addition to themed seminars and interactive workshops hosted by industry experts, addressing the most important issues in immunisation.
To find out more about the program and to register, please click on the link below to our Events page:
MVEC: Clinical Vaccinology Update (CVU) 2021
Reminder to register for the Clinical Vaccinology Update (CVU) 2021!
A reminder to register for the Clinical Vaccinology Update (CVU) 2021 taking place virtually on Thursday 18th and Friday 19th November.
This 2-day virtual program will allow participants to choose from keynote sessions delivered on our virtual main stage in addition to themed seminars and interactive workshops hosted by industry experts, addressing the most important issues in immunisation.
To find out more about the program and to register, please click on the link below to our Events page:
MVEC: Clinical Vaccinology Update (CVU) 2021
New educational resource: Generation Next course on COVID and kids
MVEC has collaborated with the team at Generation Next on a new resource featuring Dr Daryl Cheng to provide helpful strategies to get kids back to school safely and reduce transmission of COVID-19 in this group.
Course content reflects the combined efforts of immunisation paediatricians, adult physicians, immunisation nurses, infectious disease, and allergy specialists, as well as infection control teams. The information works to provide guidance and support for parents and communities to ensure a safe transition to a new COVID normal.
To enrol in this free course, please click on the link below:
Next Generation course: Covid and kids
CDC: Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years
The Centers for Disease Control and Prevention (CDC) have released a report about the effectiveness of Pfizer-BioNTech mRNA vaccination against COVID-19 hospitalization among persons aged 12–18 years.
The findings in the report suggested that among hospitalized U.S. patients aged 12–18 years, vaccine effectiveness of 2 doses of Pfizer-BioNTech vaccine against COVID-19 hospitalization during June–September 2021, was 93% (95% confidence interval = 83%–97%).
Key evaluation from the report demonstrated that 2 doses of Pfizer-BioNTech vaccine were highly effective in preventing COVID-19 hospitalization among persons aged 12–18 years, reinforcing the importance of vaccination to protect U.S. youths against severe COVID-19.
To read the report in full, please click on the link below.
CDC: Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years
Save the date for our virtual Clinical Vaccinology Update (CVU)!
MVEC are pleased to announce we will be hosting a virtual Clinical Vaccinology Update (CVU) on Thursday 18 and Friday 19 November, 2021.
Program details and ticketing information will be announced shortly via our MVEC Events Page.
New resource: The MVEC Conversation: myocarditis/pericarditis following mRNA vaccines
继我们的 CVU 迷你虚拟活动之后： 心脏问题：与 COVID-19 mRNA 疫苗接种相关的心肌炎和心包炎, 墨尔本疫苗教育中心很高兴地宣布我们的最新资源 MVEC 对话：mRNA 疫苗后的心肌炎/心包炎。
该视频播客深入探讨了这一特殊关注的不良事件 (AESI)，特邀嘉宾 Tom Shimabukuro 博士是佐治亚州亚特兰大疾病控制与预防中心 (CDC) 免疫安全办公室副主任，与 Daryl Cheng 博士和 Nigel Crawford 副教授的对话。
To find out more about this resource, please visit our MVEC Events page.